Navigation Links
Reportlinker Adds Contract Pharmaceutical Manufacturing, Research and Packaging
Date:11/3/2009

NEW YORK, Nov. 3 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.

Contract Pharmaceutical Manufacturing, Research and Packaging

http://www.reportlinker.com/p0157461/Contract-Pharmaceutical-Manufacturing-Research-and-Packaging.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

Offers a thorough review of the global market for contract manufacturing, research and packaging in the pharmaceutical business

Provides the current global market status for contract manufacturing, research, and packaging and forecasts for growth through 2014

Discusses the advantages and disadvantages of outsourcing

Covers technological issues including the latest trends and developments

Describes the regulatory environment.

Chapter- 1: INTRODUCTION -- Complimentary

STUDY OBJECTIVES 1

REASONS FOR DOING THIS STUDY 1

INTENDED AUDIENCE 2

SCOPE OF THE STUDY 2

METHODOLOGY 2

INFORMATION SOURCES 2

ABOUT THE AUTHOR 3

RELATED BCC RESEARCH REPORTS 3

BCC ONLINE SERVICES 3

DISCLAIMER 4

Chapter-2: SUMMARY

SUMMARY 5

SUMMARY TABLE WORLDWIDE PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT RESEARCH ORGANIZATIONS REVENUE, THROUGH 2014 ($ BILLIONS) 6

SUMMARY FIGURE WORLDWIDE PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT RESEARCH ORGANIZATIONS REVENUE, 2007-2014 ($ BILLIONS) 7

Chapter-3: OVERVIEW

DEFINITIONS 8

CONTRACT MANUFACTURING 8

CONTRACT MANUFACTURER 8

TYPES OF CONTRACT MANUFACTURERS 9

CORE COMPETENCIES 9

VENDOR 9

CONTRACT RESEARCH ORGANIZATION (CRO) 9

HISTORY OF OUTSOURCING 9

HISTORY OF OUTSOURCING (CONTINUED) 10

HISTORY OF OUTSOURCING (CONTINUED) 11

Chapter-4: CONTRACT MANUFACTURING

NEED FOR CONTRACT MANUFACTURING 12

FLEXIBILITY 12

CAPACITY AND CAPITAL 12

ADVANTAGES OF CONTRACT MANUFACTURING 13

TABLE 1 KEY ADVANTAGES OF CONTRACT MANUFACTURING 13

TABLE 1 (CONTINUED) 14

SELECTION OF CONTRACT MANUFACTURER 14

MISCONCEPTIONS REGARDING CONTRACT MANUFACTURERS 15

Chapter-5: CONTRACT RESEARCH

INCLUDED IN RESEARCH 16

DRUG DISCOVERY AND DEVELOPMENT 16

CLINICAL RESEARCH 17

ANALYTICAL RESEARCH 17

NEED FOR CONTRACT RESEARCH 17

SERVICES OFFERED BY CONTRACT RESEARCH ORGANIZATION 18

SELECTION AND MANAGEMENT OF CRO 18

Chapter-6: CONTRACT PACKAGING

CONTRACT PACKAGING 19

THE NEED FOR CONTRACT PACKAGING 20

CRITERIA FOR THE SELECTION OF A PACKAGING SERVICE 20

LOCATION 21

EXPERIENCE 21

PERSONALITY 21

FINANCIAL STRENGTH 21

ADVANTAGES OF CONTRACT PACKAGING 21

ADVANTAGES OF CONTRACT PACKAGING (CONTINUED) 22

Chapter-7: THE NEED FOR PROJECT MANAGEMENT

PROJECT EVALUATION AND SET UP 23

PLANNING AND EXECUTION 24

QUALITY MANAGEMENT 24

MANAGEMENT OF QUALITY COMPONENTS FROM CLIENT'S PERSPECTIVE 25

MANAGEMENT OF QUALITY COMPONENTS FROM THE CMO PERSPECTIVE 25

Management of Quality Components ... (Continued) 26

Chapter-8: REGULATORY ASPECTS

SHORT SUPPLY ARRANGEMENTS 27

DIVIDED MANUFACTURING ARRANGEMENTS 28

SHARED MANUFACTURING ARRANGEMENTS 29

RESPONSIBILITIES OF EACH PARTICIPATING MANUFACTURER 29

CONTRACT MANUFACTURING ARRANGEMENTS 30

RESPONSIBILITIES OF LICENSED MANUFACTURER 30

TABLE 2 RESPONSIBILITIES OF LICENSED MANUFACTURER UNDER FDA ACTS 31

RESPONSIBILITIES OF THE CONTRACT MANUFACTURER 31

WARNING LETTERS 32

WARNING LETTERS ISSUED TO CONTRACT MANUFACTURERS 32

Warning Letters Issued to ... (Continued) 33

APPROVALS OF MANUFACTURING FACILITIES 34

Chapter-9: INDUSTRY STRUCTURE

MARKET SHARES OF INDUSTRY LEADERS 35

CONTRACT MANUFACTURERS OF BULK DRUGS AND APIS 35

TABLE 3 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/API, 2009 (%) 35

FIGURE 1 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/API, 2009 (%) 36

CONTRACT MANUFACTURERS OF SOLID DOSAGE FORMS 36

TABLE 4 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, 2009 (%) 36

TABLE 4 (CONTINUED) 37

FIGURE 2 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, 2009 (%) 37

CONTRACT MANUFACTURERS OF LIQUID DOSAGE FORMS 38

NONSTERILE 38

TABLE 5 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING NON-STERILE LIQUID DOSAGE FORMS, 2009 (%) 38

FIGURE 3 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING NON-STERILE LIQUID DOSAGE FORMS, 2009 (%) 39

STERILE 39

TABLE 6 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, 2009 (%) 39

TABLE 6 (CONTINUED) 40

FIGURE 4 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, 2009 (%) 40

CONTRACT MANUFACTURERS OF SEMISOLID DOSAGE FORMS 40

TABLE 7 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, 2009 (%) 41

FIGURE 5 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, 2009 (%) 41

CONTRACT RESEARCH COMPANIES 41

TABLE 8 WORLDWIDE MARKET SHARES OF CONTRACT RESEARCH COMPANIES, 2009 (%) 42

FIGURE 6 WORLDWIDE MARKET SHARES OF CONTRACT RESEARCH COMPANIES, 2009 (%) 42

CONTRACT PACKAGING COMPANIES 43

TABLE 9 WORLDWIDE MARKET SHARES OF CONTRACT PACKAGING COMPANIES, 2009 (%) 43

FIGURE 7 WORLDWIDE MARKET SHARES OF CONTRACT PACKAGING COMPANIES, 2009 (%) 44

TYPES OF CONTRACT MANUFACTURING AND RESEARCH FIRMS 44

TABLE 10 SERVICES PROVIDED BY CONTRACT MANUFACTURING AND RESEARCH FIRMS 45

TABLE 10 (CONTINUED) 46

TABLE 10 (CONTINUED) 47

TABLE 10 (CONTINUED) 48

TABLE 10 (CONTINUED) 49

TABLE 10 (CONTINUED) 50

TABLE 10 (CONTINUED) 51

TABLE 10 (CONTINUED) 52

TABLE 11 SERVICES PROVIDED BY CONTRACT PACKAGING FIRMS BY PACKAGING TYPE 53

Chapter-10: TECHNOLOGY TRANSFER

REASONS FOR TECHNOLOGY TRANSFER 54

CHALLENGING PROBLEMS DURING TECHNOLOGY TRANSFER 55

PRELIMINARY STEPS TOWARD TECHNOLOGY TRANSFER 56

STEPS FOR SUCCESSFUL TECHNOLOGY TRANSFER 56

TYPES OF CONTRACTUAL AGREEMENTS USED IN TECHNOLOGY TRANSFER 57

CONFIDENTIAL DISCLOSURE AGREEMENT (CDA) 57

MATERIAL TRANSFER AGREEMENT (MTA) 58

ASSIGNMENT DEED 58

LICENSE AGREEMENT 58

CO-DEVELOPMENT AND CO-MARKETING AGREEMENTS 58

FACTORS FOR A SUCCESSFUL PROJECT 59

FACTORS FOR A SUCCESSFUL PROJECT (CONTINUED) 60

Chapter-11: NEW DEVELOPMENTS

QUINTILES INC. 61

COVANCE 62

CHARLES RIVER LABORATORIES 63

OTHERS 63

OTHERS (CONTINUED) 64

OTHERS (CONTINUED) 65

Chapter-12: MARKETS

CONTRACT MANUFACTURING 66

CONTRACT MANUFACTURE OF BULK DRUGS/APIS 66

Market Overview 66

Market Overview (Continued) 67

Market Revenue 68

TABLE 12 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ BILLIONS) 68

FIGURE 8 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS) 69

Market Shares 69

TABLE 13 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%) 70

FIGURE 9 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%) 70

CONTRACT MANUFACTURE OF ORAL DOSAGE FORMULATIONS 70

Solid Dosage Formulations 71

Market Overview 71

Market Revenue 72

TABLE 14 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ BILLIONS) 73

FIGURE 10 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS) 73

Market Shares 73

TABLE 15 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%) 74

FIGURE 11 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%) 74

Market by Formulation 75

Market Revenue 75

TABLE 16 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ BILLIONS) 76

FIGURE 12 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY FORMULATION, 2007-2014 ($ BILLIONS) 76

TABLE 17 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%) 77

FIGURE 13 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING, MARKET SHARES BY FORMULATION, 2009 (%) 77

Liquid Dosage Formulations 77

Market Overview 77

Market Overview (Continued) 78

Market Overview (Continued) 79

Non-sterile Formulations 80

Market Revenue 80

TABLE 18 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS) 80

FIGURE 14 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS) 81

Market Shares 81

TABLE 19 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%) 81

FIGURE 15 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%) 82

Sterile Formulations 82

Market Revenue 82

TABLE 20 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS) 82

FIGURE 16 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS) 83

Market Shares 83

TABLE 21 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%) 83

FIGURE 17 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%) 84

Market by Formulation 84

Non-sterile Formulations 84

TABLE 22 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ MILLIONS) 85

FIGURE 18 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, 2007-2014 ($ MILLIONS) 85

TABLE 23 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%) 86

FIGURE 19 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%) 86

Sterile Formulations 86

TABLE 24 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ MILLIONS) 87

FIGURE 20 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, 2007-2014 ($ MILLIONS) 87

TABLE 25 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%) 88

FIGURE 21 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%) 88

CONTRACT MANUFACTURE OF SEMISOLID DOSAGE FORMULATIONS 88

Market Overview 88

Market Overview (Continued) 89

Market Revenue 90

TABLE 26 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS) 90

FIGURE 22 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS) 91

Market Shares 91

TABLE 27 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%) 91

FIGURE 23 WORLDWIDE SEMI-SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%) 92

Market by Formulation 92

TABLE 28 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ MILLIONS) 93

FIGURE 24 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ MILLIONS) 93

TABLE 29 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%) 94

FIGURE 25 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%) 94

CONTRACT MANUFACTURE OF ADVANCED DRUG DELIVERY PRODUCTS 94

Contract Manufacture ...(Continued) 95

Market Overview 96

TABLE 30 CONTRACTING COMPANIES PROVIDING DRUG DELIVERY SYSTEMS 97

TABLE 30 (CONTINUED) 98

Market Revenue 98

TABLE 31 WORLDWIDE CONTRACTING COMPANIES PROVIDING ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY REGION, THROUGH 2014 ($ BILLIONS) 98

FIGURE 26 WORLDWIDE ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS) 99

Market Shares 99

TABLE 32 WORLDWIDE DRUG DELIVERY CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%) 99

FIGURE 27 WORLDWIDE DRUG DELIVERY CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%) 100

Market by Formulation 100

TABLE 33 WORLDWIDE CONTRACTING COMPANIES PROVIDING ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY TYPE, THROUGH 2014 ($ BILLIONS) 101

FIGURE 28 WORLDWIDE ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING REVENUE BY TYPE, 2007-2014 ($ BILLIONS) 101

Market Shares 102

TABLE 34 WORLDWIDE ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING SHARE BY TYPE, 2009 (%) 102

FIGURE 29 WORLDWIDE ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING REVENUE BY TYPE, 2009 (%) 103

CONTRACT MANUFACTURE OF OTC AND NUTRITIONAL PRODUCTS 103

Market Overview 104

Market Revenue 105

TABLE 35 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ BILLIONS) 106

FIGURE 30 WORLDWIDE OTC AND NUTRITIONAL PRODUCTS CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS) 106

Market Shares 107

TABLE 36 WORLDWIDE OTC AND NUTRITIONAL PRODUCTS CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%) 107

FIGURE 31 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%) 107

Market by Formulation 108

TABLE 37 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING REVENUE BY DOSAGE FORM, THROUGH 2014 ($ BILLIONS) 108

FIGURE 32 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING REVENUE BY DOSAGE FORM, 2007-2014 ($ BILLIONS) 109

TABLE 38 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARES BY DOSAGE FORM, 2009 (%) 109

FIGURE 33 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARES BY DOSAGE FORM, 2009 (%) 110

CONTRACT RESEARCH 110

MARKET OVERVIEW 110

Partnerships 110

Partnerships (Continued) 111

Expansions of Facilities 112

MARKET REVENUE 113

TABLE 39 WORLDWIDE CONTRACT PHARMACEUTICAL RESEARCH MARKET BY REGION, THROUGH 2014 ($ BILLIONS) 114

FIGURE 34 WORLDWIDE CONTRACT PHARMACEUTICAL RESEARCH MARKET BY REGION, 2007-2014 ($ BILLIONS) 114

MARKET SHARES 115

TABLE 40 WORLDWIDE CONTRACT RESEARCH MARKET SHARES BY REGION, 2009 (%) 115

FIGURE 35 WORLDWIDE CONTRACT RESEARCH MARKET SHARES BY REGION, 2009 (%) 115

MARKET BY DISCIPLINE 116

TABLE 41 WORLDWIDE CONTRACT RESEARCH REVENUE BY DISCIPLINE, THROUGH 2014 ($ BILLIONS) 116

FIGURE 36 WORLDWIDE CONTRACT RESEARCH REVENUE BY DISCIPLINE, 2007-2014 ($ BILLIONS) 117

MARKET SHARES BY DISCIPLINE 117

TABLE 42 WORLDWIDE CONTRACT RESEARCH MARKET SHARES BY DISCIPLINE, 2009 (%) 117

FIGURE 37 WORLDWIDE CONTRACT RESEARCH MARKET SHARES BY DISCIPLINE, 2009 (%) 118

CONTRACT PACKAGING 118

MARKET OVERVIEW 118

Market Overview (Continued) 119

MARKET REVENUE 119

TABLE 43 WORLDWIDE CONTRACT PACKAGING MARKET BY REGION, THROUGH 2014 ($ BILLIONS) 120

FIGURE 38 WORLDWIDE CONTRACT PACKAGING MARKET BY REGION, 2007-2014 ($ BILLIONS) 120

MARKET SHARES 121

TABLE 44 WORLDWIDE CONTRACT PACKAGING MARKET SHARES BY REGION, 2009 (%) 121

FIGURE 39 WORLDWIDE CONTRACT PACKAGING MARKET SHARES BY REGION, 2009 (%) 121

MARKET BY PACKAGE TYPE 122

MARKET REVENUE 122

TABLE 45 WORLDWIDE CONTRACT PACKAGING MARKET BY PACKAGE TYPE, THROUGH 2014 ($ BILLIONS) 123

FIGURE 40 WORLDWIDE CONTRACT PACKAGING MARKET BY PACKAGE TYPE, 2007-2014 ($ BILLIONS) 123

MARKET SHARES 123

TABLE 46 WORLDWIDE CONTRACT PACKAGING MARKET SHARES BY PACKAGE TYPE, 2009 (%) 124

FIGURE 41 WORLDWIDE CONTRACT PACKAGING MARKET SHARES BY PACKAGE TYPE, 2009 (%) 124

Chapter-13: CONTRACT MANUFACTURING APPLICATIONS

CARDIOVASCULAR DRUG MARKET 125

MARKET REVENUE 126

TABLE 47 WORLDWIDE REVENUE FROM CONTRACT MANUFACTURE OF CARDIOVASCULAR DRUGS BY REGION, THROUGH 2014 ($ MILLIONS) 126

FIGURE 42 WORLDWIDE CARDIOVASCULAR DRUG CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS) 127

REPRODUCTIVE DRUG MARKET 127

MARKET REVENUE 128

TABLE 48 WORLDWIDE REPRODUCTIVE DRUG CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS) 128

FIGURE 43 WORLDWIDE REPRODUCTIVE DRUG CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS) 129

ONCOLOGY DRUG MARKET 129

MARKET REVENUE 130

TABLE 49 WORLDWIDE ONCOLOGY DRUG AND DIAGNOSTIC CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS) 131

FIGURE 44 WORLDWIDE ONCOLOGY DRUG AND DIAGNOSTIC CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS) 131

ANALGESIC MARKET 132

MARKET REVENUE 132

TABLE 50 WORLDWIDE ANALGESIC CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS) 133

FIGURE 45 WORLDWIDE ANALGESIC CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS) 133

ANTIVIRAL DRUGS MARKET 133

MARKET REVENUE 134

TABLE 51 WORLDWIDE ANTIVIRAL DRUG CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS) 135

FIGURE 46 WORLDWIDE ANTIVIRAL DRUG CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS) 135

ANTIBIOTICS MARKET 136

MARKET REVENUE 136

TABLE 52 WORLDWIDE ANTIBIOTIC CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS) 137

FIGURE 47 WORLDWIDE ANTIBIOTIC CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS) 137

MARKETS FOR OTHER DRUGS 138

MARKET REVENUE 138

TABLE 53 WORLDWIDE OTHER DRUG CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ BILLIONS) 139

FIGURE 48 WORLDWIDE OTHER DRUG CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS) 139

Chapter-14: PATENT ANALYSIS

PATENTS BY YEAR 140

TABLE 54 NUMBER OF SIGNIFICANT PATENTS BY YEAR, 2005-2009 140

FIGURE 49 NUMBER OF PATENTS BY YEAR, 2005-2009 140

FIGURE 50 NUMBER OF PATENTS BY YEAR, 2005-2009 (%) 141

PATENTS BY COMPANY 141

TABLE 55 NUMBER OF U.S. PATENTS BY COMPANY, 2005-2009 142

PATENTS BY COUNTRY 142

TABLE 56 NUMBER OF U.S. PATENTS BY COUNTRY, 2005-2009 143

TABLE 57 PATENT SHARES BY COUNTRY, 2005-2009 (%) 143

FIGURE 51 PATENT SHARES BY COUNTRY, 2005-2009 (%) 144

PATENTS BY EMPHASIS 144

TABLE 58 PATENTS BY EMPHASIS, 2005-2009 145

Chapter-15: CURRENT ENVIRONMENT

OVERALL SITUATION OF THE CONTRACTING MARKET 146

CONTRACT MANUFACTURING OF API AND DOSAGE FORMS 146

CONTRACT MANUFACTURING OF OTC AND NUTRACEUTICALS 146

CONTRACT RESEARCH 147

CONTRACT PACKAGING 147

SUCCESS FACTORS FOR CMOS 147

PRESENT SCENARIO OF THE CONTRACT MANUFACTURING MARKET 148

FROM THE PHARMACEUTICAL COMPANIES' PERSPECTIVE 148

FROM CONTRACT MANUFACTURING ORGANIZATION'S PERSPECTIVE 149

FACTORS AFFECTING THE OUTSOURCING MARKET 149

COST CONTAINMENT 150

GLOBALIZATION 150

MERGERS AND ACQUISITIONS 150

REGULATORY REQUIREMENTS 151

NEED FOR SPECIALIZED SERVICES 151

COMPETITION WITHIN THE PHARMACEUTICAL INDUSTRY 151

INTRODUCTION OF NEW BIOTHERAPEUTICS 151

Chapter-16: COMPANY PROFILES

AAI PHARMA, INC. 152

ABBOTT LABORATORIES 152

AEROGEN, INC. 153

ALBANY MOLECULAR RESEARCH, INC. 153

ALCAN PACKAGING 154

ALKERMES, INC. 154

AMERISOURCE BERGEN 155

A. P. PHARMA, INC. 155

ARADIGM CORPORATION 156

BAXTER HEALTHCARE 157

BEN VENUE LABORATORIES INC. 157

BIOVAIL CORP. 158

BOEHRINGER INGELHEIM 158

BOOTS MANUFACTURING 159

CAMBREX CORP. 159

CANGENE 160

CATALENT PHARMA SOLUTIONS 160

CEDARBURG HAUSER PHARMACEUTICAL LTD. 161

CENEXI 161

CHARLES RIVER LABORATORIES 162

CHEMBRIDGE CORP. 162

CONFAB LABORATORIES 163

COVANCE INC. 163

DAVOS PHARMA 164

DECODE GENETICS 164

DIOSYNTH BIOTECHNOLOGY 165

DISHMAN PHARMACEUTICALS AND CHEMICALS LTD. 165

DOW CHEMICAL COMPANY 166

DPT LABORATORIES INC. 166

DR REDDY'S LABORATORIES 167

DSM PHARMACEUTICAL PRODUCTS 167

ELAN DRUG TECHNOLOGIES 168

EVOTEC AG 168

FULCRUM PHARMA PLC 169

GENZYME PHARMACEUTICALS 169

GIRINDUS AG 170

GLAXOSMITHKLINE BIOPHARMACEUTICALS 170

HOVIONE S.A. 171

JUBILANT ORGANOSYS 171

KENDLE INTERNATIONAL INC. 172

KING PHARMACEUTICALS 172

KP PHARMACEUTICAL TECHNOLOGIES INC 173

K.V. PHARMACEUTICAL CO. 173

LIGAND PHARMACEUTICALS 174

LONZA GROUP 174

LYNE LABORATORIES 175

MALLINCKRODT 175

MDS PHARMA SERVICES 176

MEDAREX INC. 176

MIKART INC 177

NORWICH PHARMACEUTICALS 177

NOVAVAX, INC. 177

OMNICARE CLINICAL RESEARCH 178

PAREXEL INTERNATIONAL CORPORATION 178

PATHEON INC. 179

PERRIGO COMPANY 179

PHARMACEUTICAL PRODUCT DEVELOPMENT INC. 180

PIRAMAL HEALTHCARE 180

PRA INTERNATIONAL 181

QUINTILES 181

RANBAXY RESEARCH LABS 182

REGIS TECHNOLOGIES, INC. 182

SCHWARZ PHARMA AG 183

SKYEPHARMA 183

TALECRIS BIOTHERAPEUTICS INC. 184

WUXI APP TEC 184

XCELLEREX, LLC 185

APPENDIX : ABBREVIATIONS 186

APPENDIX 186

APPENDIX (CONTINUED) 187

To order this report:

Contract Pharmaceutical Manufacturing, Research and Packaging

http://www.reportlinker.com/p0157461/Contract-Pharmaceutical-Manufacturing-Research-and-Packaging.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

More market research reports here!

    Nicolas Bombourg
    Reportlinker
    Email: nbo@reportlinker.com
    US: (805)652-2626
    Intl: +1 805-652-2626

SOURCE Reportlinker


'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved


Related medicine technology :

1. Reportlinker Adds Gastrointestinal Pharmaceuticals: Technologies and Markets
2. Reportlinker Adds Chinese Markets for Bladder Cancer Treatment Drugs
3. Reportlinker Adds Chinese Markets for Respiratory Drugs
4. Reportlinker Adds Driving Successful Pharma Brands: Case Studies of Real Product Launches
5. Reportlinker Adds Ion Channel Modulator Pipelines: Targets and Agents in Development
6. Reportlinker Adds Medical Devices & Equipment in India (2009)
7. Reportlinker Adds Outsourcing Preclinical Studies to China
8. Reportlinker Adds Competitor Analysis: PI3K-AKT-mTOR Inhibitors
9. Reportlinker Adds Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile
10. Reportlinker Adds Allergan Inc.: PharmaVitae Profile
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... , Feb. 4, 2016 Worldwide ... achieve significant growth as next generation systems provide ... use radiology for cancer surgery. New systems pinpoint ... overdosing that has been such a problem previously, ... delivered. Radiosurgery robots take cancer surgery far beyond ...
(Date:2/4/2016)... 2016 Wegener Polyangiitis - Pipeline Review, ... ,Wegener Polyangiitis - Pipeline Review, H2 2015, provides ... This report provides comprehensive information on the ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ...
(Date:2/4/2016)... LONDON , Feb. 4, 2016 ... and competitive market to drive long-term market growth ... very common set of chronic disorders that affect ... disparate in terms of their symptoms and key ... by dysregulation of immune pathways and an inappropriate ...
Breaking Medicine Technology:
(Date:2/5/2016)... New York (PRWEB) , ... February 05, 2016 , ... ... use and find themselves having to wait longer to access the treadmills. It’s a ... New Year’s resolutions to lose weight and get in shape by joining gyms, starting ...
(Date:2/5/2016)... ... , ... At its annual meeting held last week, the American Parkinson Disease ... of Directors. Mr. McDermott succeeds former APDA Chairman, Fred Greene. , "We are pleased ... APDA President and CEO. “Pat has tirelessly served APDA since 2001 when he was ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Colorize ... on one drop zone to the next using Colorize's dynamic moving camera. Colorize is ... This package includes a 3D slideshow environment with 1 to 5 focus points per ...
(Date:2/5/2016)... ... 05, 2016 , ... On June 9-10, Las Vegas will ... education (CME) event presented by the Association for Comprehensive Care in Rare Diseases ... whose mission is to provide education, tools, and resources to primary care clinicians ...
(Date:2/5/2016)... Luis Obispo, CA (PRWEB) , ... February 05, 2016 , ... ... new changes that Medicare San Luis Obispo users can expect to see in 2016. ... , The two most significant changes will directly impact many San Luis Obispo seniors ...
Breaking Medicine News(10 mins):